CY1115089T1 - Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας - Google Patents

Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Info

Publication number
CY1115089T1
CY1115089T1 CY20141100109T CY141100109T CY1115089T1 CY 1115089 T1 CY1115089 T1 CY 1115089T1 CY 20141100109 T CY20141100109 T CY 20141100109T CY 141100109 T CY141100109 T CY 141100109T CY 1115089 T1 CY1115089 T1 CY 1115089T1
Authority
CY
Cyprus
Prior art keywords
diversity
lactobacillus plantarum
person
bacterial diversity
sibo
Prior art date
Application number
CY20141100109T
Other languages
English (en)
Inventor
Göran Molin
Siv Ahrne
Caroline Karlsson
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of CY1115089T1 publication Critical patent/CY1115089T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την αύξηση της ποικιλότητας του γαστρεντερικού σωλήνα με χορήγηση του εν λόγω στελέχους σε ένα άτομο με σκοπό την παραγωγή αυξημένου δείκτη ποικιλότητας σε σύγκριση με placebo, καθώς και η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την προφυλακτική θεραπεία υγιούς ατόμου έναντι της εμφάνισης χαμηλής βακτηριακής ποικιλότητας (LBD), ατόμου που έχει LBD έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, βακτηριακής υπερανάπτυξης παχέος εντέρου (LIBO) ή βακτηριακής υπερανάπτυξης λεπτού εντέρου (SIBO), και ενός ατόμου που έχει LIBO ή SIBO έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, και μέθοδος για την αύξηση της εν λόγω ποικιλότητας.
CY20141100109T 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας CY1115089T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0700551 2007-03-01
EP08741827.3A EP2136825B1 (en) 2007-03-01 2008-02-29 Use of lactobacillus plantarum for increasing bacterial diversity

Publications (1)

Publication Number Publication Date
CY1115089T1 true CY1115089T1 (el) 2016-12-14

Family

ID=39673143

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100109T CY1115089T1 (el) 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Country Status (19)

Country Link
US (1) US8586026B2 (el)
EP (1) EP2136825B1 (el)
JP (2) JP5829005B2 (el)
KR (1) KR101510691B1 (el)
CN (1) CN101674840B (el)
AU (1) AU2008219818B2 (el)
BR (1) BRPI0808522A8 (el)
CA (1) CA2679480C (el)
CY (1) CY1115089T1 (el)
DK (1) DK2136825T3 (el)
ES (1) ES2446942T3 (el)
HR (1) HRP20140080T1 (el)
NZ (1) NZ579330A (el)
PL (1) PL2136825T3 (el)
PT (1) PT2136825E (el)
RU (1) RU2521364C2 (el)
SI (1) SI2136825T1 (el)
WO (1) WO2008105715A2 (el)
ZA (1) ZA200906534B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP3311825A1 (en) * 2010-08-04 2018-04-25 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
HK1253538A1 (zh) * 2010-08-04 2019-06-21 Borody Thomas J 用於糞便菌群植入的組合物及其製備和使用方法
EP2683390B1 (en) 2011-03-09 2017-05-03 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
AU2016262615C1 (en) 2015-05-14 2021-06-10 Finch Therapeutics Holdings Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN114366759A (zh) 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
EP3790995A1 (en) * 2018-05-08 2021-03-17 F. Hoffmann-La Roche AG Method of cancer prognosis by assessing tumor variant diversity by means of establishing diversity indices
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
TWI706783B (zh) * 2018-07-18 2020-10-11 大江生醫股份有限公司 延緩老化之益生菌株及其組合物與用途
JP2022514145A (ja) 2018-09-27 2022-02-10 フィンチ セラピューティクス ホールディングス エルエルシー てんかんおよび関連する障害を治療するための組成物および方法
US20230033606A1 (en) 2019-12-17 2023-02-02 Metagenics, Inc. Multi-strain probiotic composition and its use
FR3122084B1 (fr) 2021-04-21 2023-10-27 Mirei Int Ltd Composition cosmétique ou pharmaceutique caractérisée par une association de bioactifs sélectionnés à partir de graines deGlycine max pour son utilisation dans la modulation du microbiote intestinal et cutanée et l’équilibre de l’axe intestin-peau-cerveau.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
RU2247148C2 (ru) * 2002-05-28 2005-02-27 Пименов Евгений Васильевич Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP4320408B2 (ja) * 2005-04-21 2009-08-26 学校法人明治大学 胆汁酸結合能を有する新規菌株
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption

Also Published As

Publication number Publication date
JP6162749B2 (ja) 2017-07-12
SI2136825T1 (sl) 2014-04-30
US20100143463A1 (en) 2010-06-10
EP2136825A2 (en) 2009-12-30
US8586026B2 (en) 2013-11-19
AU2008219818A1 (en) 2008-09-04
JP2015164952A (ja) 2015-09-17
CA2679480A1 (en) 2008-09-04
BRPI0808522A8 (pt) 2017-10-10
AU2008219818B2 (en) 2013-06-27
WO2008105715A3 (en) 2008-10-30
BRPI0808522A2 (pt) 2015-02-10
JP5829005B2 (ja) 2015-12-09
NZ579330A (en) 2012-02-24
DK2136825T3 (da) 2014-02-24
EP2136825B1 (en) 2013-11-20
WO2008105715A2 (en) 2008-09-04
KR101510691B1 (ko) 2015-04-10
CN101674840B (zh) 2014-05-21
CA2679480C (en) 2016-10-18
PL2136825T3 (pl) 2014-04-30
ZA200906534B (en) 2010-11-24
RU2009136328A (ru) 2011-04-10
CN101674840A (zh) 2010-03-17
HRP20140080T1 (hr) 2014-03-14
JP2010520234A (ja) 2010-06-10
KR20090127415A (ko) 2009-12-11
RU2521364C2 (ru) 2014-06-27
ES2446942T3 (es) 2014-03-10
PT2136825E (pt) 2014-02-21

Similar Documents

Publication Publication Date Title
CY1115089T1 (el) Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας
ECSP13012776A (es) Inmunoglobulinas de dominio variable dual
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
EA201101530A1 (ru) ИММУНОНАНОТЕРАПИЯ, ОБЕСПЕЧИВАЮЩАЯ Th1-СМЕЩЕННЫЙ ОТВЕТ
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
WO2010141803A3 (en) Bioartificial lung
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2011011670A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas.
EA201370208A1 (ru) Формы рифаксимина и их применение
MY151137A (en) Probiotics to improve gut microbiota
CO6650372A2 (es) Proteínas de unión de dominio variable dual que se unen a tnfy tweak, y métopdos para hacer y usar dichas proteínas
ECSP10010643A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
TWD143734S1 (zh) 手鐲
TWD148180S (zh) 運動滾筒
DE602007009382D1 (de) Stent mit variablem stauchdurchmesser
MX2010001692A (es) Ciertas entidades quimicas, composiciones y metodos.
ECSP077340A (es) Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
WO2010006809A3 (en) Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
EA201190283A1 (ru) Мультивалентный адъювантный дисплей
MY151104A (en) Novel use
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
NZ588663A (en) Anti-viral nutraceutical
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus